Founded in 2018, Illumax focuses on the R&D and manufacturing of single-dose chemiluminescence system, multiplex immunoassay system, and auxiliary diagnostic reagents. We are committed to establishing an open CDMO platform for single-dose chemiluminescence system and multiplex immunoassay system.

The company has rich technological accumulation in fields such as chemiluminescence system, multiplex immunoassay system, core components, encoded microspheres, auxiliary diagnostic reagents, and has a number of innovative technology patents.

Our core team has more than 10 years of experience in IVD product research and industrialization. We are committed to the mission of "precision diagnostics within touch" and strive to provide customers with affordable and accurate diagnostic products anytime, anywhere, for anyone. (5A-level)

At present, our products have been well received by customers in Europe, the Middle East, South Asia, South America, Africa and major domestic provinces, cities and autonomous regions. The company has been rated as a high-tech enterprise, a technology-based small and medium-sized enterprise in Sichuan Province, and a professional innovative enterprise in Sichuan Province.

Illumax will always adhere to hard-core innovation and is committed to becoming a global advocate of accurate diagnosis!